{
    "2018-07-11": [
        [
            {
                "time": "2018-07-12",
                "original_text": "Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for July 12, 2018",
                "features": {
                    "keywords": [
                        "Abbott Laboratories",
                        "Ex-Dividend",
                        "Date",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-12",
                "original_text": "AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for July 12, 2018",
                "features": {
                    "keywords": [
                        "AbbVie Inc.",
                        "Ex-Dividend",
                        "Date",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-12",
                "original_text": "Pacira (PCRX) Issues Strong Preliminary Exparel Sales for Q2",
                "features": {
                    "keywords": [
                        "Pacira",
                        "Strong",
                        "Preliminary",
                        "Exparel",
                        "Sales",
                        "Q2"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-12",
                "original_text": "Benzinga's Daily Biotech Pulse: Pfizer To Defer Price Hikes, Idera-BioCryst Merger Falls Through, ArQule To Offer Shares",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Defer",
                        "Price",
                        "Hikes",
                        "Idera-BioCryst",
                        "Merger",
                        "Falls",
                        "Through",
                        "ArQule",
                        "Offer",
                        "Shares"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-12",
                "original_text": "Idorsia raises 505 mln Sfr from shares, bonds to fund pipeline",
                "features": {
                    "keywords": [
                        "Idorsia",
                        "raises",
                        "505",
                        "mln",
                        "Sfr",
                        "shares",
                        "bonds",
                        "fund",
                        "pipeline"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}